Production (Stage)
Organogenesis Holdings Inc.
ORGO
$3.03
$0.155.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -21.17% | 27.10% | 6.12% | 11.01% | 2.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -21.17% | 27.10% | 6.12% | 11.01% | 2.17% |
| Cost of Revenue | -17.33% | 11.82% | 3.90% | 10.95% | 7.85% |
| Gross Profit | -22.53% | 33.00% | 6.82% | 11.03% | 0.30% |
| SG&A Expenses | 0.26% | 24.20% | 11.96% | 8.66% | 0.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.11% | 17.61% | 8.52% | 12.65% | 3.73% |
| Operating Income | -423.86% | 1,474.58% | -23.36% | -7.38% | -84.04% |
| Income Before Tax | -493.67% | 670.88% | -23.75% | -258.41% | 6.14% |
| Income Tax Expenses | -209.41% | 310.10% | -245.59% | -35.21% | -35.28% |
| Earnings from Continuing Operations | -797.29% | 1,450.88% | 289.36% | -420.60% | 29.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -797.29% | 1,450.88% | 289.36% | -420.60% | 29.27% |
| EBIT | -423.86% | 1,474.58% | -23.36% | -7.38% | -84.04% |
| EBITDA | -13,234.71% | 201.75% | -10.67% | 0.25% | -93.39% |
| EPS Basic | -975.47% | 1,153.49% | 285.89% | -417.53% | 29.65% |
| Normalized Basic EPS | -361.65% | 8,133.33% | -25.27% | -9.74% | -58.46% |
| EPS Diluted | -755.00% | 1,032.56% | 350.00% | -425.00% | 11.50% |
| Normalized Diluted EPS | -361.65% | 7,983.33% | -24.86% | -8.47% | -58.46% |
| Average Basic Shares Outstanding | -4.22% | -0.95% | 0.96% | 0.97% | 0.59% |
| Average Diluted Shares Outstanding | -4.22% | 0.23% | 0.38% | -0.37% | 0.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |